Table 4.
Polyclonal immunoglobulin measures | ||
---|---|---|
Measure | Difference in serum levels [mg/dL] in relatives (95% CI) | p -Value |
FLC(κ + λ) | − 0.2 (− 0.6,0.2) | 0.33 |
IgA(κ + λ) | − 15.8 (− 41.6,10) | 0.23 |
IgG(κ+λ) | − 9.8 (− 69.1,49.5) | 0.75 |
IgM(κ+λ) | 16.0 (1.3,30.6) | 0.033 |
Monoclonal immunoglobulin measuresa | ||
Measure | Fold difference for monoclonality in relatives (95% CI) | p -Value |
FLC (κ/λ) | 6.38 (1.65,34.97) | 0.0063 |
IgA(κ/λ) | 0.95 (0.3,2.76) | 0.93 |
IgG(κ/λ) | 1.44 (0.48,4.24) | 0.51 |
IgM(κ/λ) | 0.49 (0.12,1.52) | 0.23 |
Propensity-score adjustment with matching on sex and age was used to control imbalances and nonlinearity in sex and age distributions between relatives and controls; p-values are from the Wald’s test. Polyclonal Ig variables are quantitative traits and are tested within a linear regression framework. Average differences in relatives compared with controls and 95% confidence intervals (CIs) are reported. Monoclonal Ig variables are dichotomous and tested within a logistic regression framework. Fold differences for monoclonality (abnormal κ/λ ratio, free, or bound) and 95% CI are reported from the logistic model. aAbnormality for FLC ratio (κ/λ) is based on its established diagnostic range (0.26–1.65). Abnormal HLC ratios are based on the 95% reference range from controls as follows: 0.84–1.91 for IgA(κ/λ); 1.02–2.87 for IgG(κ/λ); and 1.00–2.90 for IgM(κ/λ). Table entries that are bold and italic indicate those that are statistically different between at-risk relatives and controls